John T. Treace, Chief Executive Officer at TREACE MEDICAL CONCEPTS, INC. (TMCI), bought 60,000 shares at $8.73 ($524K) on 2025-03-04, disclosed to the SEC on 2025-03-04.
Seasonal purchase ($524k) by Chief Executive Officer — this insider has traded TMCI in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| TMCI | BUY | 2026-06-11 | $211K | — | Filing → |
| TMCI | BUY | 2026-06-01 | $178K | — | Filing → |
| TMCI | BUY | 2026-05-28 | $341K | — | Filing → |